Green tea has shown to exert cardioprotective benefits in observational studies; however, a randomized controlled trial conducted on 35 subjects with MetS showed that the daily consumption of green tea beverage containing 110 mg of EGCG for 8 weeks had no significant effect on insulin sensitivity or on biomarkers of inflammation [86]. The gene discussed is INS; the disease is metabolic syndrome.